# PLCB4

## Overview
PLCB4 is a gene that encodes the enzyme phospholipase C beta 4 (PLCβ4), a member of the phospholipase C family, which plays a pivotal role in intracellular signal transduction. As a phospholipase, PLCβ4 is involved in the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) to generate the second messengers inositol trisphosphate (IP3) and diacylglycerol (DAG), which are crucial for calcium signaling pathways (Lee1994Regulation; Jiang1994Activation). The protein is characterized by a conserved structure that includes domains such as the pleckstrin homology (PH) domain and EF-hand motifs, which are essential for its function and regulation (Vines2012Phospholipase; Katan2020Phospholipase). PLCβ4 is expressed in various tissues, including the retina and brain, where it is involved in processes such as visual processing and neural signaling (Jiang1996Phospholipase; Ikeda2009Phospholipase). Mutations in PLCB4 have been linked to clinical conditions like auriculocondylar syndrome and are implicated in cancer progression, highlighting its significance in both normal physiology and disease (Li2017PLCB4; Rieder2012A).

## Structure
PLCB4 (phospholipase C beta 4) is a member of the phospholipase C family, characterized by a conserved core structure that includes several domains essential for its function. The protein contains an N-terminal pleckstrin homology (PH) domain, which is involved in phosphoinositide binding and membrane interactions (Vines2012Phospholipase; Katan2020Phospholipase). It also features four EF-hand motifs, which are helix-loop-helix structures that play a role in calcium binding, crucial for the enzyme's activation (Vines2012Phospholipase). The catalytic domain of PLCB4 is composed of two conserved halves, known as the X and Y domains, which form a TIM-barrel-like structure involved in substrate recognition and catalysis (Vines2012Phospholipase; Katan2020Phospholipase).

PLCB4 is known to have several splice variants, which can result in isoforms with distinct structural features and functions. For instance, some variants lack the PH domain and the first EF-hand motif, replaced by unique amino-terminal regions (Rebecchi2000Structure). These structural variations can influence the enzyme's localization and interaction with other proteins, impacting its role in signal transduction pathways (Rebecchi2000Structure).

## Function
Phospholipase C beta 4 (PLCβ4) is an enzyme that plays a critical role in intracellular signal transduction by hydrolyzing phosphatidylinositol 4,5-bisphosphate (PIP2) to generate two second messengers: inositol trisphosphate (IP3) and diacylglycerol (DAG). This reaction leads to the release of calcium from the endoplasmic reticulum and the activation of protein kinase C, which are essential for various cellular functions (Lee1994Regulation; Jiang1994Activation).

PLCβ4 is involved in several physiological processes, including vision and neural signaling. It is expressed in the retina, lateral geniculate nucleus, and superior colliculus, indicating its role in visual processing. In the retina, PLCβ4 is thought to modulate visual responses beyond the initial phototransduction cascade, possibly through interactions between rods and other retinal cells (Jiang1996Phospholipase).

In the brain, PLCβ4 is expressed in regions such as the thalamus and cerebellum, where it is involved in regulating sleep and body temperature rhythms. It couples with group-1 metabotropic glutamate receptors, influencing intracellular calcium signaling and contributing to the regulation of sleep episodes and thermoregulation (Ikeda2009Phospholipase).

## Clinical Significance
Mutations in the PLCB4 gene are associated with several clinical conditions, most notably auriculocondylar syndrome (ACS). ACS is a rare autosomal-dominant craniofacial malformation syndrome characterized by features such as micrognathia, temporomandibular joint ankylosis, cleft palate, and distinctive ear malformations. Mutations in PLCB4, including missense mutations like p.Tyr623Cys, p.Asn329Ser, p.Arg621His, and p.Asn650His, disrupt the catalytic function of the protein, affecting mandibular patterning and potentially altering MAPK signaling pathways (Rieder2012A). These mutations are often found in highly conserved regions of the gene, indicating their evolutionary importance (Rieder2012A).

PLCB4 is also implicated in osteoporosis susceptibility. A polymorphism in the PLCB4 promoter, rs6086746, affects the binding affinity of the RUNX2 transcription factor, leading to increased PLCB4 expression and a higher risk of osteoporosis (Tsai2021The).

In gastrointestinal stromal tumors (GISTs), PLCB4 overexpression is linked to tumor progression and poor prognosis. Increased PLCB4 expression, often due to copy gain, correlates with larger tumor size and higher mitotic rates (Li2017PLCB4).

Additionally, PLCB4 mutations have been identified in uveal melanoma, where they act as likely driver mutations, suggesting a role in cancer progression (Johansson2015Deep).

## Interactions
PLCB4 (phospholipase C beta 4) is involved in several protein interactions that are crucial for its function in signal transduction pathways. It is activated by G proteins, particularly the Gαq subunit, which facilitates the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol trisphosphate (IP3) and diacylglycerol (DAG), key second messengers in calcium signaling pathways (Lyon2013Structural; Jiang1996Phospholipase).

PLCB4 is also implicated in the MAPK and VEGF signaling pathways, which are significant in various cellular processes, including cell growth and survival. These interactions suggest a role for PLCB4 in modulating these pathways, potentially influencing cancer progression and resistance mechanisms, such as in metastatic colorectal cancer (Lee2023In).

Mutations in PLCB4 have been associated with auriculocondylar syndrome, affecting the endothelin-DLX5/6 pathway, which is crucial for craniofacial development. These mutations can disrupt the catalytic function of PLCB4, affecting its interactions within this pathway and leading to phenotypic variability in the syndrome (Rieder2012A).


## References


[1. (Lyon2013Structural) Angeline M. Lyon and John J. G. Tesmer. Structural insights into phospholipase c-βfunction. Molecular Pharmacology, 84(4):488–500, July 2013. URL: http://dx.doi.org/10.1124/mol.113.087403, doi:10.1124/mol.113.087403. This article has 102 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1124/mol.113.087403)

[2. (Rebecchi2000Structure) Mario J. Rebecchi and Srinivas N. Pentyala. Structure, function, and control of phosphoinositide-specific phospholipase c. Physiological Reviews, 80(4):1291–1335, January 2000. URL: http://dx.doi.org/10.1152/physrev.2000.80.4.1291, doi:10.1152/physrev.2000.80.4.1291. This article has 770 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1152/physrev.2000.80.4.1291)

[3. (Jiang1994Activation) H. Jiang, D. Wu, and M.I. Simon. Activation of phospholipase c beta 4 by heterotrimeric gtp-binding proteins. Journal of Biological Chemistry, 269(10):7593–7596, March 1994. URL: http://dx.doi.org/10.1016/s0021-9258(17)37328-3, doi:10.1016/s0021-9258(17)37328-3. This article has 82 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(17)37328-3)

[4. (Rieder2012A) Mark J. Rieder, Glenn E. Green, Sarah S. Park, Brendan D. Stamper, Christopher T. Gordon, Jason M. Johnson, Christopher M. Cunniff, Joshua D. Smith, Sarah B. Emery, Stanislas Lyonnet, Jeanne Amiel, Muriel Holder, Andrew A. Heggie, Michael J. Bamshad, Deborah A. Nickerson, Timothy C. Cox, Anne V. Hing, Jeremy A. Horst, and Michael L. Cunningham. A human homeotic transformation resulting from mutations in plcb4 and gnai3 causes auriculocondylar syndrome. The American Journal of Human Genetics, 90(5):907–914, May 2012. URL: http://dx.doi.org/10.1016/j.ajhg.2012.04.002, doi:10.1016/j.ajhg.2012.04.002. This article has 75 citations.](https://doi.org/10.1016/j.ajhg.2012.04.002)

[5. (Lee1994Regulation) C W Lee, K H Lee, S B Lee, D Park, and S G Rhee. Regulation of phospholipase c-beta 4 by ribonucleotides and the alpha subunit of gq. Journal of Biological Chemistry, 269(41):25335–25338, October 1994. URL: http://dx.doi.org/10.1016/s0021-9258(18)47252-3, doi:10.1016/s0021-9258(18)47252-3. This article has 92 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(18)47252-3)

[6. (Katan2020Phospholipase) Matilda Katan and Shamshad Cockcroft. Phospholipase c families: common themes and versatility in physiology and pathology. Progress in Lipid Research, 80:101065, November 2020. URL: http://dx.doi.org/10.1016/j.plipres.2020.101065, doi:10.1016/j.plipres.2020.101065. This article has 54 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.plipres.2020.101065)

[7. (Jiang1996Phospholipase) Huiping Jiang, Arkady Lyubarsky, Robert Dodd, Noga Vardi, Edward Pugh, Denis Baylor, Melvin I. Simon, and Dianqing Wu. Phospholipase c β4 is involved in modulating the visual response in mice. Proceedings of the National Academy of Sciences, 93(25):14598–14601, December 1996. URL: http://dx.doi.org/10.1073/pnas.93.25.14598, doi:10.1073/pnas.93.25.14598. This article has 108 citations.](https://doi.org/10.1073/pnas.93.25.14598)

[8. (Tsai2021The) Dung-Jang Tsai, Wen-Hui Fang, Li-Wei Wu, Ming-Cheng Tai, Chung-Cheng Kao, Shih-Ming Huang, Wei-Teing Chen, Po-Jen Hsiao, Chih-Chien Chiu, Wen Su, Chia-Chun Wu, and Sui-Lung Su. The polymorphism at plcb4 promoter (rs6086746) changes the binding affinity of runx2 and affects osteoporosis susceptibility: an analysis of bioinformatics-based case-control study and functional validation. Frontiers in Endocrinology, November 2021. URL: http://dx.doi.org/10.3389/fendo.2021.730686, doi:10.3389/fendo.2021.730686. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2021.730686)

[9. (Johansson2015Deep) Peter Johansson, Lauren G. Aoude, Karin Wadt, William J. Glasson, Sunil K. Warrier, Alex W. Hewitt, Jens Folke Kiilgaard, Steffen Heegaard, Tim Isaacs, Maria Franchina, Christian Ingvar, Tersia Vermeulen, Kevin J. Whitehead, Christopher W. Schmidt, Jane M. Palmer, Judith Symmons, Anne-Marie Gerdes, Göran Jönsson, and Nicholas K. Hayward. Deep sequencing of uveal melanoma identifies a recurrent mutation in plcb4. Oncotarget, 7(4):4624–4631, December 2015. URL: http://dx.doi.org/10.18632/oncotarget.6614, doi:10.18632/oncotarget.6614. This article has 231 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.6614)

[10. (Lee2023In) Cheng-Chin Lee, Ai-Wei Lee, Po-Li Wei, Yi-Shin Liu, Yu-Jia Chang, and Chien-Yu Huang. In silico analysis to identify mir-1271-5p/plcb4 (phospholipase c beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer. Scientific Reports, March 2023. URL: http://dx.doi.org/10.1038/s41598-023-31331-2, doi:10.1038/s41598-023-31331-2. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-023-31331-2)

[11. (Vines2012Phospholipase) Charlotte M. Vines. Phospholipase C, pages 235–254. Springer Netherlands, 2012. URL: http://dx.doi.org/10.1007/978-94-007-2888-2_10, doi:10.1007/978-94-007-2888-2_10. This article has 47 citations.](https://doi.org/10.1007/978-94-007-2888-2_10)

[12. (Li2017PLCB4) Chien-Feng Li, Ting-Ting Liu, I-Chieh Chuang, Yen-Yang Chen, Fu-Min Fang, Ti-Chun Chan, Wan-Shan Li, and Hsuan-Ying Huang. Plcb4 copy gain and plcß4 overexpression in primary gastrointestinal stromal tumors: integrative characterization of a lipid-catabolizing enzyme associated with worse disease-free survival. Oncotarget, 8(12):19997–20010, February 2017. URL: http://dx.doi.org/10.18632/oncotarget.15306, doi:10.18632/oncotarget.15306. This article has 22 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.15306)

[13. (Ikeda2009Phospholipase) Masayuki Ikeda, Moritoshi Hirono, Takashi Sugiyama, Takahiro Moriya, Masami Ikeda-Sagara, Naomi Eguchi, Yoshihiro Urade, and Tohru Yoshioka. Phospholipase c-β4 is essential for the progression of the normal sleep sequence and ultradian body temperature rhythms in mice. PLoS ONE, 4(11):e7737, November 2009. URL: http://dx.doi.org/10.1371/journal.pone.0007737, doi:10.1371/journal.pone.0007737. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0007737)